Green Signal for Kintor Pharma, PD-L1/TGF-β dual-targeting antibody (GT90008) for Tumour Clinical Trail from China NMPA
Kintor Pharmaceutical Limited (“Kintor Pharma”, HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced that the clinical trial of…